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Inadvertent leakage of medications with vesicant properties can cause severe necrosis in tissue, which
can have devastating long-term consequences. The aim of this study was to evaluate the extent of ex-
travasation injury induced by thiopental and propofol, and the effects of cooling or warming of local
tissue on extravasation injury at macroscopic and histopathologic levels. Rats were administered in-
tradermally thiopental (2.5 mg/100 mL) or propofol (1.0 mg/100 mL). Rats were assigned randomly to
three groups: control (no treatment), cooling and warming. Local cooling (18–20 °C) or warming (40–
42 °C) was applied for 3 h immediately after agent injection. Lesion sizes (erythema, induration, ul-
ceration, necrosis) were monitored after agent injection. Histopathology was evaluated in skin biopsies
taken 24 h after agent injection. Thiopental injection induced severe skin injury with necrosis. Peak
lesions developed within 24 h and healed gradually 18–27 days after extravasation. Propofol induced
inﬂammation but no ulceration, and lesions healed within 1–2 days. Local cooling reduced thiopental-
and propofol-induced extravasation injuries but warming strongly exacerbated the skin lesions (e.g.,
degeneration, necrosis) induced by extravasation of thiopental and propofol. Thiopental can be classiﬁed
as a “vesicant” that causes tissue necrosis and propofol can be classiﬁed as an “irritant”. Local cooling
protects (at least in part) against skin disorders induced by thiopental and propofol, whereas warming is
harmful.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Accidental leakage of certain medications into the body from
an intravenous drip is not uncommon. Inadvertent leakage of
medications with vesicant properties can cause severe necrosis in
tissue, which can have devastating long-term consequences. Most
instances of extravasation are attributed to cytotoxic agents, and
the prevalence has been reported to be 0.1–6% [1,2]. In addition,
several non-cytotoxic agents have been reported to possess vesi-
cant properties due to their high osmolarity, extremely acidic or
basic pH, and vasoconstrictive activity [3]. Several guidelines for
overall management of extravasation have suggested that re-
cognition of potential risks for each agent is important so that
clinicians can manage extravasation depending on the severity ofB.V. This is an open access article u
cal Services, Hiroshima Uni-
a 734-8551, Japan.such risks [4,5]. Intravenous cytotoxic agents can be classiﬁed into
three categories according to the extent of damage from extra-
vasation: vesicants, irritants, and non-tissue-damaging agents
[1,2,4]. Vesicants can cause tissue necrosis even at small volumes
of extravasation because they are inherently toxic to cells. Irritants
can cause an inﬂammatory reaction (but not necrosis) at the ex-
travasation site. Non-tissue-damaging agents do not damage tis-
sue at all.
Thiopental and propofol are used for the induction and main-
tenance of anesthesia. Extravasation of these agents is common
because anaesthetized patients cannot indicate pain during in-
jection [6]. Risk of extravasation injury is increased because pro-
pofol is administered forcefully using automated syringe drivers.
Several case reports from 1961 through to 2014 have highlighted
extravasation by thiopental or propofol [3]. It is well known that
thiopental can act as a vesicant [7] and propofol can act as an ir-
ritant [8–11]. However, few reports have shown the vesicant ef-
fects of propofol [12–14]. Thus, the risk of skin lesions induced by
propofol extravasation is understood incompletely because datander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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injuries according to the potential risks of agents. Hence, classiﬁ-
cation of non-cytotoxic agents into the three categories described
above (as well as cytotoxic agents) depending on their toxicity
would be useful.
Prompt interdisciplinary management of tissue damage in-
duced by extravasated agents is important for successful therapy.
Several reports have shown that stopping the drug infusion as well
as surgical excision, thermal application and/or pharmacologic
interventions aid management of injury due to extravasation of
agents [4,5]. Cooling or warming of local tissue are major sup-
portive measures to reduce skin lesions induced by certain agents
[1,3,4,15]. According to one overview of extravasation manage-
ment [16], hospitals should ensure the availability of “extravasa-
tion kits containing cold–hot packs” at the treatment unit. How-
ever, there is little scientiﬁc basis for the effects of poultices on
skin lesions. With regard to management of thiopental extra-
vasation, warming is recommended by the manufacturer, though
there is no evidence to indicate therapeutic effects. With respect to
management of propofol extravasation, only one report has shown
that cooling reduces pain [17]. Thus, the usefulness of cooling or
warming of local tissue to manage injuries induced by extravasa-
tion of thiopental or propofol is not known.
In the present study, we ﬁrst evaluated the extent of extra-
vasation injuries induced by thiopental or propofol and classiﬁed
these agents (as well as cytotoxic agents) on the basis of macro-
scopic and histopathologic evaluations of skin damage. Next, the
effects of local cooling or warming on extravasation injury were
evaluated to provide a comprehensive view of management stra-
tegies for extravasation of thiopental and propofol.2. Materials and methods
2.1. Animals
All experiments were carried out in accordance with the Guide
for Animal Experimentation from the Committee of Research Facilities
for Laboratory Animal Sciences of Hiroshima University (permit
number: A15-31).
Thirty-three male Wistar albino rats (8 weeks; body weight,
250–270 g) were obtained from Japan SLC, Inc. (Shizuoka, Japan).
Rats were housed in individual cages in a temperature-controlled
room at 23 °C on a 12-h light–dark cycle. They were fed a standard
laboratory diet (MF, Oriental Yeast Company, Tokyo, Japan) and
water ad libitum for 41 week before experimentation.
2.2. Extravasation models
Rats were anesthetized with pentobarbital (40 mg/kg, i.p.).
According to a previous report [18], the hair on the back of rats
was shaved with an electrical clipper (Thrive 2100; Daito Electric
Machine Industry Co. Ltd., Osaka, Japan). Sodium thiopental (Ra-
vonals; Tanabe–Mitsubishi, Osaka, Japan) was dissolved at 2.5 mg/
100 mL in water for injection according to manufacturer instruc-
tions. Twenty-four hours after hair removal, rats with no wounds
were injected intradermally (i.d.) with a solution of thiopental or
propofol (1.0 mg/100 mL of Diprivans; AstraZeneca, Osaka, Japan)
at 100 mL (the minimum volume at which lesions can be observed
macroscopically). As a negative control group, physiologic (0.9%)
saline was injected (i.d.) at 100 mL as well as thiopental and pro-
pofol. Intradermal injections were undertaken after grabbing
dorsal skin using a 26-G needle at the center of a hair-free site
7 cm from the ear. Two injections were made on the axisymmetric
dorsal side of each rat. Right-side lesions were monitored until the
injury healed completely. Left-side lesions were punch-biopsied(using a dermal punch) 24 h after intradermal injection for his-
topathologic evaluation under anesthesia with pentobarbital.
2.3. Cooling and warming of local tissue
Rats that had undergone intradermal injection of thiopental or
propofol were assigned randomly to three experimental groups of
5 rats each: no treatment (control); cooling (treatment with a cold
pack); warming (treatment with a hot pack). Cooling and warming
of local tissue were done for 3 h immediately after intradermal
injection using cold or hot packs (3M HealthCare, Tokyo, Japan),
respectively [19]. Three rats were assigned to a group in which
saline was injected via the intradermal route without treatment.
Skin temperature was monitored every 10 min using electronic
thermocouple probes (BTM-4208SD; Sato-Tech, Kanagawa, Japan),
and was maintained at 18–20 °C or 40–42 °C for cooling and
warming, respectively.
2.4. Macroscopic evaluation
Extravasation injury to skin was evaluated macroscopically
according to a method described previously [18]. Brieﬂy, the
widest perpendicular diameters of skin lesions were measured
using a caliper by an investigator blinded to group allocation. Each
lesion site was inspected every day during the ﬁrst week after
intradermal injection, then every 5 days from day-7. Four para-
meters of lesions (erythema, induration, ulceration, necrosis) were
assessed. The area of lesion sites was calculated in cm2 as the
product of diameters [18]. The area under the lesion–time curve
(AUC) was calculated in cm2 days using the trapezoidal method
[18]. The AUC, peak area of the lesion, and damage duration were
analyzed until the injury healed completely.
2.5. Histopathologic evaluation
Lesion sites were biopsied (using a dermal punch) with a dia-
meter of 4 mm at 24 h after intradermal injection according to the
peak time of lesions using phenytoin (which is thought to possess
strong alkaline properties similar to those of thiopental) [20].
Tissue samples were suspended in 10% formaldehyde for ﬁxation
before dehydration, Sections (5 mm) from the parafﬁn-embedded
tissue blocks were stained with hematoxylin and eosin, in addition
to standard histopathologic evaluation under a light microscope
(BX51; Olympus, Tokyo, Japan). Each sample was analyzed by in-
dependent pathologists blinded to the experimental procedure.
2.6. Statistical analyses
Data are the mean7standard error of the mean (SEM). Dif-
ferences among each treatment group were analyzed using Krus-
kal–Wallis test followed by the Student Newman–Keuls multiple-
comparison post hoc test. Po0.05 was considered signiﬁcant.3. Results
3.1. Macroscopic ﬁndings
For saline-injected rats, no change was observed at any injec-
tion site. In thiopental-treated rats, skin lesions developed im-
mediately and reached maximal intensity within 24 h after injec-
tion (Fig. 1a). At 2–3 days after thiopental injection, the epidermis
had regenerated and exhibited eschar formation, granulation and
excoriation of necrotic sites. Typical shape of these skin lesions
was ovoid, and induration, erythema, and ulceration (in des-
cending order of size) were observed. Epidermal integrity was
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Fig. 1. Effects of local cooling or warming on macroscopic injury induced by
thiopental (a) or propofol (b) extravasation in rats. Thiopental (2.5 mg) or propofol
(1.0 mg) were administered intradermally (ID) at a volume of 100 mL. Local cooling
(18–20 °C) and warming (40–42 °C) were performed for 3 h immediately after ID of
thiopental or propofol. Remaining lesions were monitored until the injury was
healed completely. Open circles, closed circles and closed squares represent lack of
treatment, cooling and warming, respectively. Each value represents the mean7-
SEM of results from ﬁve rats. *Po0.05, **Po0.01: signiﬁcantly different from
controls (non-treatment).
Table 1
Effects of local cooling or warming on thiopental- and propofol-induced skin lesion
parameters in rats.
Agent/Treatment Peak area (cm2) AUC (cm2 days) Damage duration (days)
Thiopental
None 3.970.2 42.072.3 20.970.9
Cooling 3.370.2 31.572.1 17.671.1*
Warming 6.670.5** 98.476.2** 26.871.3**
Propofol
None 1.070.2 1.370.3 1.570.2
Cooling 0.370.1* 0.370.1 1.170.2
Warming 2.270.2** 3.770.7** 2.270.3
AUC, area under the lesion-time curve. Thiopental (2.5 mg) and propofol (1.0 mg)
were administered intradermally (ID) at a volume of 100 mL. Local cooling (18–
20 °C) and warming (40–42 °C) were performed for 3 h immediately after ID of
thiopental or propofol. Remaining lesions were monitored until the injury was
completely healed. Each value represents the mean7SEM of results from ﬁve rats.
* Po0.05.
** Po0.01: signiﬁcantly different from controls (non-treatment).
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proved skin lesions as represented by the peak area of lesions,
AUC, and damage duration (po0.05). Warming signiﬁcantly in-
creased the peak area and AUC by E1.7-fold (po0.01) and 2.3-
fold (po0.01) compared with those in the control group, respec-
tively (Table 1). Damage duration was also extended by E6 days
in warming-treated rats compared with that in control rats
(po0.01). Propofol injection also induced maximal skin lesions
within 24 h (as shown in thiopental-treated rats). Lesions in pro-
pofol-treated rats had subtle erythema but no ulceration (unlike
those in thiopental-treated rats). Propofol-induced lesions healed
within 2 days compared with the 18–27 days needed by thio-
pental-treated rats (Fig. 1b and Table 1). Thus, the extent of pro-
pofol-induced lesions was much milder compared with that in-
duced by thiopental. Local cooling reduced the peak area
(po0.05), AUC and damage duration, whereas warming increased
the peak area (po0.01), AUC (po0.01) and damage duration
(Table 1).3.2. Histopathologic ﬁndings
In saline-treated control rats, skin tissue showed cells with
intact architecture as well as regular morphology of skin tissue
(Fig. 2a, b). At 24 h after thiopental injection, degeneration, edema,
necrosis and inﬁltration of inﬂammatory cells were observed in
epidermal, dermal and subcutaneous tissues (Fig. 2c, d). In good
agreement with macroscopic ﬁndings, local cooling suppressed
the edema and degeneration in muscle seen in thiopental-treated
rats, suggesting that cooling also reduced the skin disorders
caused by thiopental injection at the morphologic level (Fig. 2e, f).
In contrast, warming promoted more severe degeneration and
necrosis in epidermal, dermal, subcutaneous tissues, blood-vessel
walls and muscle compared with those in untreated rats (Fig. 2g,
h). Some nuclear debris was observed in the deep dermis of these
warmed rats. These results clearly suggested that skin lesions in-
duced by thiopental injection in warmed rats was the most severe
among the three groups. Propofol injection did not result in ne-
crosis, but led to more inﬂammatory cells inﬁltrating into dermal
and subcutaneous tissues and muscle in untreated controls com-
pared with those in thiopental-treated rats. Furthermore, cooling
and warming did not affect the lesions of propofol-injected rats at
the histopathologic level (Fig. 3).4. Discussion
Recognition of the potential risks for extravasation of agents is
very important. However, the risks of extravasation injury induced
by thiopental and propofol are understood incompletely because
extravasation injuries caused by these agents has not been eval-
uated at macroscopic and histopathologic levels. We examined the
intrinsic risks of extravasation injury by thiopental and propofol
and classiﬁed them into three categories according to macroscopic
and histopathologic ﬁndings of skin damage using a rat model.
Effects of local cooling or warming of tissue on extravasation in-
jury were also evaluated.
Thiopental injection induced skin lesions such as erythema,
induration, ulceration and tissue necrosis within 24 h after its
extravasation (Fig. 1a). In good agreement with macroscopic
ﬁndings, histopathologic evaluation of skin lesions showed de-
generation, edema, and necrosis in the epidermal, dermal and
subcutaneous tissues of thiopental-treated rats within 24 h
(Fig. 2). These results suggest that extravasation injury due to
thiopental is severe, and we classiﬁed thiopental as a “vesicant”.
With respect to the mechanism of tissue damage from extra-
vasation of non-cytotoxic agents, the high osmolarity, acidic or
alkaline pH and/or vasoconstrictive activity have been reported
[3]. According to manufacturer instructions, thiopental injection
leads to an osmotic pressure ratio of 0.8 and alkaline pH of 10.2–
11.2. Thus, the ulceration and necrosis induced by thiopental could
be attributed to its alkalinity rather than its osmolarity. Propofol
caused an inﬂammatory reaction with erythema, but ulceration
was not observed macroscopically in the extravasation site. His-
topathologic evaluation showed that propofol exerted no vesicant
effects (including induction of necrosis though the increased
number of inﬂammatory cells inﬁltrating into the dermis and
subcutaneous tissue) (Fig. 3). Thus, we categorized propofol as an
“irritant”, in agreement with previous reports [8–11]. Propofol has
been recognized as a less invasive drug because of its chemical
properties, isotonicity, and neutral pH (7.0–8.5) [8]. However, even
a less invasive agent such as propofol can induce tissue injury if
large volumes of solution are extravasated because high hydro-
static pressures lead to tissue ischemia [21,22]. Propofol can leak
readily because it is injected forcefully using automated syringe
drivers. Thus, tissue compression by large volumes of extravasated
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Fig. 2. Effects of local cooling or warming on histopathological skin lesions induced by thiopental extravasation in rats. Normal skin (a, b) after intradermal injection (ID) of
saline shows complete architectural construction of dermis, skin appendixes, epithelium (E), dermis (D), muscle (M), hair follicle (H), sebaceous glands (SG), vessel (V).
Control (c, d) is a group without any treatment after ID of thiopental (2.5 mg). Cooling treated with cold pack (18–20 °C) for 3 h immediately after thiopental ID, reduced
edema (e, f). Warming treated with hot pack (40–42 °C) for 3 h immediately after thiopental ID, caused degeneration and necrosis in the deep dermis and muscle (g, h).
Hematoxylin and eosin stain: (a, c, e, g) magniﬁcation4; (b, d, f, h) magniﬁcation20.
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Fig. 3. Effects of local cooling or warming on histopathological skin lesions induced by propofol extravasation in rats. Normal skin (a, b) after intradermal injection (ID) of
saline shows complete architectural construction of dermis, skin appendixes, epithelium (E), dermis (D), muscle (M), hair follicle (H), sebaceous glands (SG), vessel (V).
Control (c, d) is a group without any treatment after ID of propofol (1.0 mg). Cooling (e, f) treated with cold pack (18–20 °C) for 3 h immediately after propofol ID and
warming (g, h) treated with hot pack (40–42 °C) for 3 h immediately after propofol ID. Skin tissues were biopsied at 24 h after ID of saline or propofol. Hematoxylin and eosin
stain: (a, c, e, g) magniﬁcation4; (b, d, f, h) magniﬁcation20.
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extravasated propofol. In addition, several reports have shown that
skin necrosis by propofol is involved in malnutrition and predis-
position to the bleeding caused by sepsis and diabetes mellitus
[12,23,24]. Thus, further study is needed to conﬁrm that propofol
is an irritant by distinguishing the intrinsic risk properties of
agents and other risk factors (e.g., physical destruction of tissue
due to excess accumulation of injected ﬂuid in connective tissues).
With regard to the management of extravasation injury in-
duced by cytotoxic agents, application of cooling or warming and
pharmacologic agents (e.g., dexrazoxane for anthracycline and
hyaluronidase) has been reported [25]. We examined the effects of
cooling or warming on extravasation injury induced by thiopentaland propofol because these supportive measures are conservative.
Cooling reduced the severity of thiopental-induced lesions, in-
cluding edema and necrosis in dermal, subcutaneous and in-
tramuscular tissue. The mechanism of injury reduction by cooling
may be due to the induction of vasoconstriction, which results in
reduced dispersion of these agents [25]. Dorr et al. reported that
warming can reduce the extravasation injury caused by vinca al-
kaloids though mechanisms that are understood incompletely
[26]. In contrast, in our study, warming exacerbated rather than
improved the extravasation injury caused by thiopental at mac-
roscopic and histopathologic levels. Warming also exacerbated the
severity of macroscopic skin lesions in propofol-treated rats, but
exerted no histopathologic changes in propofol-treated rats
Y. Shibata et al. / Biochemistry and Biophysics Reports 8 (2016) 207–211 211(Fig. 3). The reason for this difference in the effect of warming on
propofol-induced injury at macroscopic and histopathologic levels
is not clear. Dispersion of these agents away from the extravasa-
tion site, and promotion of an inﬂammatory reaction and/or ede-
ma resulting from the increased blood circulation by warming,
could be considered as mechanisms of exacerbation [1,3,15].
Conversely, local warming in combination with an acidic agent
(e.g., lidocaine) could improve the extravasation injury induced by
alkaline agents because warming enhances the neutralization of
alkaline agents by lidocaine resulting from promotion of their
dispersion [3].
Studies have shown that dimethyl sulfoxide (DMSO) improves
anthracycline-induced tissue injuries by scavenging free radicals
[27,28]. Extravasation of alkaline agents, as well as anthracycline
agents, generates free radicals such as the hydroxide radical [29].
Hence, topical administration of DMSO could enable scavenging of
the free radicals generated by extravasated alkaline agents. DMSO
also promotes redistribution of poorly water-soluble extravasated
agents from lesions into the systemic blood circulation by in-
creasing their solubility [25]. Thiopental and propofol are poorly
soluble in water but have high solubility in DMSO. Thus, a com-
bination of topical DMSO and cooling applied after extravasation
could improve the skin lesions induced by these agents by
scavenging free radicals and/or promoting removal of these agents
from tissues to a greater extent compared with cooling alone.
Systematic methods of cooling and warming, such as the
compression time and temperature for extravasation injury, have
not been determined [22]. Multiple cooling or warming poultices
have been applied to reduce extravasation injury (e.g., four-times
daily for 20-min each for 1–2 days) [29]. Protection, rest, ice,
compression, and elevation have been used for ankle-joint sprains
[30] and muscle bruises, as has cryotherapy [31]. Thus, multiple
cooling may be effective for treatment of the skin lesions induced
by thiopental and propofol. Oyama et al. reported that a single 3-h
cooling session caused a greater reduction in counts of in-
ﬂammatory cells expressing C5a receptor 1 and interleukin-8 re-
ceptor, and a peripheral nerve ﬁber bundle expressing transient
receptor potential vanilloid type 1 than four-times daily cooling for
20 min in doxorubicin-injected mice [32], suggesting that using a
poultice for 20 min may not be sufﬁcient to treat the extravasation
injury cause by vesicants. However, so far, there are no data de-
monstrating whether multiple cooling or single cooling is more
relevant to treat skin lesions induced by extravasated thiopental
and propofol. In our study, single cooling at 18–20 °C for 3 h re-
duced the inﬂammation and ulceration caused by thiopental and
propofol. Thus, we recommended use of a cool poultice for the 3 h
to treat the extravasation injury by thiopental or propofol. Warm
compresses must be avoided to treat the extravasation injury
caused by these agents. This information could provide a reference
for identiﬁcation of the risk of extravasation of propofol or thio-
pental, and management of such extravasation.Acknowledgments
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